Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Shares Outstanding (2016 - 2025)

Angiodynamics (ANGO) has disclosed Shares Outstanding for 15 consecutive years, with $42.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 1.78% year-over-year to $42.2 million, compared with a TTM value of $42.2 million through Nov 2025, up 1.78%, and an annual FY2025 reading of $41.6 million, down 99.9% over the prior year.
  • Shares Outstanding was $42.2 million for Q4 2025 at Angiodynamics, roughly flat from $42.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $41.4 billion in Q3 2024 and bottomed at $39.9 million in Q4 2022.
  • Average Shares Outstanding over 5 years is $28.0 billion, with a median of $39.5 billion recorded in 2021.
  • The sharpest move saw Shares Outstanding plummeted 99.9% in 2023, then soared 101946.48% in 2024.
  • Year by year, Shares Outstanding stood at $39.5 billion in 2021, then rose by 1.06% to $39.9 billion in 2022, then rose by 1.81% to $40.6 billion in 2023, then crashed by 99.9% to $41.4 million in 2024, then grew by 1.78% to $42.2 million in 2025.
  • Business Quant data shows Shares Outstanding for ANGO at $42.2 million in Q4 2025, $42.1 million in Q3 2025, and $41.6 million in Q2 2025.